Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of an NMDA-based Intervention on Biomarker Measures of Cognitive Dysfunction in Schizophrenia

NCT00817336 is registered in ClinicalTrials.gov with Nathan Kline Institute for Psychiatric Research as lead sponsor.

NCT NCT00817336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00817336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of an NMDA-based Intervention on Biomarker Measures of Cognitive Dysfunction in Schizophrenia
Lead sponsor
Nathan Kline Institute for Psychiatric Research
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
July 31, 2011
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia